Costa-Garcia, M http://orcid.org/0000-0002-1930-6048
Rojas, JJ http://orcid.org/0000-0002-3705-6767
Ramos, MD
Barlabé, P http://orcid.org/0000-0002-1559-6498
Calvo, P
Navas, J
Alemany, R http://orcid.org/0000-0001-8660-550X
Moreno, R http://orcid.org/0000-0001-9957-3105
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer (IDEAS21912MORE, IDEAS21912MORE)
Generalitat de Cataluña (2021SGR00895, 2021SGR00895)
Instituto de Salud Carlos III (RD21/0017/0032, RD21/0017/0032)
Article History
Received: 23 August 2023
Accepted: 13 November 2023
First Online: 5 January 2024
Declarations
:
: RA declares to be a part-time employee and stock holder of Theriva Biologics.